Edinburgh Research Explorer Moving beyond silos

obstetric sepsis) and to look for an integrated approach that will provide evidence-basedpersonalizedcare to women wherever they encounter the health system. Accurate out- come prediction models are a powerful way to identify individuals at incrementally increased (and decreased) risks associated with a given condition. Integrating models with decision algorithms into mobile health (mHealth) applications could support community and fi rst level facility healthcare providers to identify those women, fetuses, and newborns most at need of facility-based care, and to initiate lifesaving interventions in their communities prior to transportation. In our opinion, this offers the greatest opportunity to provide distributed individualized care at scale, and soon. ©2015PublishedbyElsevierIrelandLtd.onbehalfofInternationalFederationofGynecologyandObstetrics.This

[1]  Naharmal B. Soni,et al.  Effectiveness of pulse-oximetry in addition to routine neonatal examination in detection of congenital heart disease in asymptomatic newborns , 2015, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[2]  A. Shennan,et al.  An accurate semiautomated oscillometric blood pressure device for use in pregnancy (including pre-eclampsia) in a low-income and middle-income country population: the Microlife 3AS1-2 , 2015, Blood pressure monitoring.

[3]  Jai K. Das,et al.  Evidence from district level inputs to improve quality of care for maternal and newborn health: interventions and findings , 2014, Reproductive Health.

[4]  Jai K. Das,et al.  Evidence from community level inputs to improve quality of care for maternal and newborn health: interventions and findings , 2014, Reproductive Health.

[5]  Jai K. Das,et al.  Evidence from facility level inputs to improve quality of care for maternal and newborn health: interventions and findings , 2014, Reproductive Health.

[6]  T. Peter,et al.  Accurate Early Infant HIV Diagnosis in Primary Health Clinics Using a Point-of-Care Nucleic Acid Test , 2014, Journal of acquired immune deficiency syndromes.

[7]  Guo-ying Huang,et al.  Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study , 2014, The Lancet.

[8]  S. Mills,et al.  Is there any role for community involvement in the community-based health planning and services skilled delivery program in rural Ghana? , 2014, BMC Health Services Research.

[9]  D. Ben-Zeev,et al.  Mobile health (mHealth) for mental health in Asia: objectives, strategies, and limitations. , 2014, Asian journal of psychiatry.

[10]  L. Magee,et al.  Predicting complications in pre-eclampsia: external validation of the fullPIERS model using the PETRA trial dataset. , 2014, European journal of obstetrics, gynecology, and reproductive biology.

[11]  Özge Tunçalp,et al.  Global causes of maternal death: a WHO systematic analysis. , 2014, The Lancet. Global health.

[12]  R. Mehran,et al.  Pre-eclampsia and future cardiovascular risk among women: a review. , 2014, Journal of the American College of Cardiology.

[13]  Guy Albert Dumont,et al.  Development of mHealth Applications for Pre-Eclampsia Triage , 2014, IEEE Journal of Biomedical and Health Informatics.

[14]  Prabhat Jha,et al.  Maternal Mortality in India: Causes and Healthcare Service Use Based on a Nationally Representative Survey , 2014, PloS one.

[15]  L. Mackillop,et al.  Diagnostic Accuracy of Placental Growth Factor in Women With Suspected Preeclampsia: A Prospective Multicenter Study , 2013, Circulation.

[16]  L. Jovanovič,et al.  Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline , 2013, The Journal of clinical endocrinology and metabolism.

[17]  K. Moons,et al.  Diagnostic and prognostic prediction models , 2013, Journal of thrombosis and haemostasis : JTH.

[18]  Robert E Black,et al.  Global burden of childhood pneumonia and diarrhoea , 2013, The Lancet.

[19]  B. Payne,et al.  Performance of the fullPIERS model in predicting adverse maternal outcomes in pre‐eclampsia using patient data from the PIERS (Pre‐eclampsia Integrated Estimate of RiSk) cohort, collected on admission , 2013, BJOG : an international journal of obstetrics and gynaecology.

[20]  G. Dumont,et al.  Improving maternal and perinatal outcomes in the hypertensive disorders of pregnancy: A vision of a community‐focused approach , 2012, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[21]  L. Magee,et al.  Preeclampsia in low and middle income countries-health services lessons learned from the PRE-EMPT (PRE-Eclampsia-Eclampsia Monitoring, Prevention and Treatment) project. , 2012, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[22]  Shoo K. Lee,et al.  Transport Risk Index of Physiologic Stability, Version II (TRIPS-II): A Simple and Practical Neonatal Illness Severity Score , 2012, American Journal of Perinatology.

[23]  L. Magee,et al.  Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction? , 2012, American journal of obstetrics and gynecology.

[24]  L. Magee,et al.  Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays. , 2011, American journal of obstetrics and gynecology.

[25]  J. Hutcheon,et al.  Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia. , 2011, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[26]  J. Hutcheon,et al.  The role of platelet counts in the assessment of inpatient women with preeclampsia. , 2011, Journal of Obstetrics and Gynaecology Canada.

[27]  Edgardo Abalos,et al.  How to manage hypertension in pregnancy effectively. , 2011, British journal of clinical pharmacology.

[28]  K. Joseph,et al.  Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. , 2011, Best practice & research. Clinical obstetrics & gynaecology.

[29]  J. Hutcheon,et al.  Using clinical symptoms to predict adverse maternal and perinatal outcomes in women with preeclampsia: data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) study. , 2011, Journal of Obstetrics and Gynaecology Canada.

[30]  Ziguang Qu,et al.  Oxygen saturation as a predictor of adverse maternal outcomes in women with preeclampsia. , 2011, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[31]  Z. Bhutta,et al.  Stillbirths: the vision for 2020 , 2011, The Lancet.

[32]  J. Hutcheon,et al.  Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model , 2011, The Lancet.

[33]  A. Shennan,et al.  Development of an accurate oscillometric blood pressure device for low resource settings , 2008, Blood pressure monitoring.

[34]  Lelia Duley,et al.  Cost‐effectiveness of prophylactic magnesium sulphate for 9996 women with pre‐eclampsia from 33 countries: economic evaluation of the Magpie Trial , 2006, BJOG : an international journal of obstetrics and gynaecology.

[35]  M. Schull,et al.  Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study , 2005, The Lancet.

[36]  Z. Bhutta,et al.  Community-Based Interventions for Improving Perinatal and Neonatal Health Outcomes in Developing Countries: A Review of the Evidence , 2005, Pediatrics.

[37]  D. Fernando,et al.  Pregnancy--reducing maternal deaths and disability in Sri Lanka: national strategies. , 2003, British medical bulletin.

[38]  J. Pell,et al.  Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births , 2001, The Lancet.

[39]  W. Mower,et al.  Pulse oximetry as a fifth pediatric vital sign. , 1997, Pediatrics.

[40]  The Surfaxin-Lavage for Mas Trial Group.  Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial , 1995, The Lancet.

[41]  D. Maine,et al.  Too far to walk: maternal mortality in context. , 1991, Social science & medicine.

[42]  G. Dumont,et al.  Assessing the incremental value of blood oxygen saturation (SpO(2)) in the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) Risk Prediction Model. , 2015, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.